{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T02:35:21Z","timestamp":1765334121223,"version":"3.46.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.compbiolchem.2025.108697","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:42:37Z","timestamp":1759300957000},"page":"108697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Designing and computational studies of Novel 5-Fluorouracil hybrids as thymidylate synthase inhibitors for targeting non small cell lung cancer"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2822-700X","authenticated-orcid":false,"given":"Dishank","family":"Purandare","sequence":"first","affiliation":[]},{"given":"Prajakta","family":"Adsule","sequence":"additional","affiliation":[]},{"given":"Rahul","family":"Jawarkar","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6576-4753","authenticated-orcid":false,"given":"Aryaa","family":"Nigade","sequence":"additional","affiliation":[]},{"given":"Satish","family":"Polshettiwar","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108697_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA a Cancer J. Clin."},{"key":"10.1016\/j.compbiolchem.2025.108697_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177494","article-title":"Unravelling key signaling pathways for the therapeutic targeting of non-small cell lung cancer","author":"Chavan","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.compbiolchem.2025.108697_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115600","article-title":"Discovery of novel thymidylate synthase (TS) inhibitors that influence cancer angiogenesis and metabolic reprogramming in NSCLC cells","volume":"258","author":"Dong","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.compbiolchem.2025.108697_bib4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1517\/13543784.2011.617742","article-title":"Thymidylate synthase inhibitors for non-small cell lung cancer","volume":"20","author":"Galvani","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"24","key":"10.1016\/j.compbiolchem.2025.108697_bib5","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/jcc.23361","article-title":"QSARINS: a new software for the development, analysis, and validation of QSAR MLR models","volume":"34","author":"Gramatica","year":"2013","journal-title":"J. Comput. Chem."},{"issue":"15","key":"10.1016\/j.compbiolchem.2025.108697_bib6","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.3390\/ijms20153821","article-title":"Epidermal growth factor receptor (EGFR) pathway, YES-Associated protein (YAP) and the regulation of programmed Death-Ligand 1 (PD-L1) in Non-Small cell lung cancer (NSCLC)","volume":"20","author":"Hsu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiolchem.2025.108697_bib7","article-title":"Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: exploring drug design, structure-activity relationship, and docking studies","volume":"279","author":"I, A","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108697_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-014-0373-0","article-title":"PD-1\/PD-L1 pathway in non-small-cell lung cancer and its relation with EGFR mutation","volume":"13","author":"Ji","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.compbiolchem.2025.108697_bib9","article-title":"Diagnosis of early-stage non-small cell lung cancer using DNA methylation in tissue and plasma","author":"Li","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.compbiolchem.2025.108697_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.crad.2025.106826","article-title":"A nomogram-based survival prediction model for non-small cell lung cancer patients based on clinical risk factors and multi-region radiomics features","volume":"84","author":"Nishioka","year":"2025","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.compbiolchem.2025.108697_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/10732748211038735","article-title":"Cancer biology, epidemiology, and treatment in the 21st century: current status and future challenges from a biomedical perspective","volume":"28","author":"Pi\u00f1a-S\u00e1nchez","year":"2021","journal-title":"Cancer Control"},{"issue":"9","key":"10.1016\/j.compbiolchem.2025.108697_bib12","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"PKCSM: predicting small molecule pharmacokinetic and toxicity properties using Graph-Based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.compbiolchem.2025.108697_bib13","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/cancers12061475","article-title":"Non-Small-Cell lung cancer signaling pathways, metabolism, and PD-1\/PD-L1 antibodies","volume":"12","author":"Santarpia","year":"2020","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.compbiolchem.2025.108697_bib14","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1007\/s00210-024-03020-y","article-title":"An insight into thymidylate synthase inhibitor as anticancer agents: an explicative review","volume":"397","author":"Sen","year":"2024","journal-title":"NaunynSchmiede S Arch. Pharmacol."},{"issue":"7","key":"10.1016\/j.compbiolchem.2025.108697_bib15","doi-asserted-by":"crossref","first-page":"986","DOI":"10.4161\/cbt.7.7.6181","article-title":"Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil: is it time to move forward?","volume":"7","author":"Showalter","year":"2008","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108697_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41416-020-01095-x","article-title":"Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer","volume":"124","author":"Siddiqui","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.compbiolchem.2025.108697_bib17","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1634\/theoncologist.2015-0084","article-title":"Targeting the KRAS pathway in Non-Small cell lung cancer","volume":"21","author":"Tomasini","year":"2016","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108697_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108697_bib19","article-title":"Time to surgery in Early-Stage Non-Small cell lung cancer (NSCLC): defining the optimal Diagnosis-to-Resection interval to reduce mortality","author":"Tupper","year":"2024","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108697_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.vacun.2023.12.003","article-title":"A review on non-small cell lung cancer","volume":"25","author":"Verma","year":"2024","journal-title":"Vacunas"},{"key":"10.1016\/j.compbiolchem.2025.108697_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1384301","article-title":"Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticancer and antiinflammatory agents","volume":"12","author":"Xu","year":"2024","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108697_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-12487-5","article-title":"Chemoresistance mechanisms to 5-Fluorouracil and reversal strategies in lung and breast cancer","volume":"15","author":"Zhong","year":"2025","journal-title":"Sci. Rep."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125003585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125003585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T02:33:10Z","timestamp":1765333990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927125003585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":22,"alternative-id":["S1476927125003585"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108697","relation":{},"ISSN":["1476-9271"],"issn-type":[{"type":"print","value":"1476-9271"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing and computational studies of Novel 5-Fluorouracil hybrids as thymidylate synthase inhibitors for targeting non small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108697"}}